Adage Capital Partners
IMGN

Adage Capital Partners’s Immunogen Inc IMGN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-971,928
Closed -$28.8M 971
2023
Q4
$28.8M Buy
971,928
+771,928
+386% +$22.9M 0.06% 331
2023
Q3
$3.17M Sell
200,000
-450,000
-69% -$7.14M 0.01% 711
2023
Q2
$12.3M Sell
650,000
-16,982,815
-96% -$320M 0.03% 528
2023
Q1
$67.7M Buy
17,632,815
+6,513,815
+59% +$25M 0.15% 163
2022
Q4
$55.2M Buy
11,119,000
+3,219,000
+41% +$16M 0.13% 189
2022
Q3
$37.8M Sell
7,900,000
-3,686,193
-32% -$17.6M 0.09% 232
2022
Q2
$52.1M Hold
11,586,193
0.12% 178
2022
Q1
$55.2M Buy
11,586,193
+1,300,000
+13% +$6.19M 0.1% 190
2021
Q4
$76.3M Buy
10,286,193
+2,536,193
+33% +$18.8M 0.14% 157
2021
Q3
$43.9M Buy
7,750,000
+750,000
+11% +$4.25M 0.09% 237
2021
Q2
$46.1M Buy
7,000,000
+2,500,000
+56% +$16.5M 0.09% 226
2021
Q1
$36.5M Buy
4,500,000
+2,025,000
+82% +$16.4M 0.07% 287
2020
Q4
$16M Buy
+2,475,000
New +$16M 0.03% 477